Form 4 · Filed May 5, 2026, 09:02 PM UTC
TERN/Terns Pharmaceuticals, Inc.
Kuriakose Emil — Chief Medical Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a full AI thesis attached (deeper analysis on flagged buys).
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moDeep AI theses on flagged setups + cluster-buy alerts + insider-CIK watchlists.
- · Everything in Pro
- · Deep AI thesis on flagged buys
- · Cluster-buy alerts (multiple insiders, same ticker, short window)
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 5, 2026 | U | sell | 24,562 | $53 | $1,301,786 | 0 |
| May 5, 2026 | D | other | 81,953 | $53 | $4,343,509 | 0 |
| May 5, 2026 | D | other | 485,000 | — | — | 0 |
| May 5, 2026 | D | other | 117,500 | — | — | 0 |
| May 5, 2026 | D | other | 120,000 | — | — | 0 |
| May 5, 2026 | D | other | 280,000 | — | — | 0 |
| May 5, 2026 | D | other | 112,500 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001892413-26-000008